![Pankaj Bhargava](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pankaj Bhargava
Directeur Général chez
ashibio, Inc.
Profil
Pankaj Bhargava was the founder of Medocity, Inc., founded in 2013, where the title held was Advisor.
Dr. Bhargava is the founder of ashibio, Inc., founded in 2022, holding the title of Chief Executive Officer.
Current jobs include Board Of Director at Presidio Graduate School since 2019, Director at Tizona Therapeutics, Inc., and Entrepreneur Partner at MPM BioImpact LLC since 2021.
Former jobs include Co-Director-Gastrointestinal Oncology Program at University of Massachusetts Medical Center, Chief Medical Officer at Gilead Sciences, Inc., Chief Medical Officer at Dicerna Pharmaceuticals, Inc. from 2014 to 2017, Principal at Dana-Farber Cancer Institute, Inc., Vice President-Clinical Research at AVEO Pharmaceuticals, Inc. from 2006 to 2011, Associate Vice President at Sanofi-Aventis U.S.
LLC from 2011 to 2014, and Chief Medical Officer at Arch Oncology, Inc. from 2016 to 2017.
Education includes graduate degree from the University of Delhi.
Postes actifs de Pankaj Bhargava
| Sociétés | Poste | Début |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2021 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Directeur/Membre du Conseil | - |
Presidio Graduate School
 Presidio Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/2019 |
ashibio, Inc.
 ashibio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for patients with rare bone and connective tissue disorders | Directeur Général | 01/01/2022 |
Anciens postes connus de Pankaj Bhargava
| Sociétés | Poste | Fin |
|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Corporate Officer/Principal | 31/12/2017 |
| DICERNA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2017 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Corporate Officer/Principal | 01/03/2014 |
| AVEO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Provides home health care services | Fondateur | - |
Formation de Pankaj Bhargava
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Medocity, Inc.
Medocity, Inc. Medical/Nursing ServicesHealth Services Provides home health care services | Health Services |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
University of Massachusetts Medical Center | |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Presidio Graduate School
Presidio Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
ashibio, Inc.
ashibio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for patients with rare bone and connective tissue disorders | Health Technology |
